51 related articles for article (PubMed ID: 33882454)
1. Novel Circular RNA CircUBAP2 Drives Tumor Progression by Regulating the miR-143/TFAP2B Axis in Prostate Cancer.
Lv Z; Shi Y; Wu H; Cao K; Liu X; Wang C
Protein Pept Lett; 2024; 31(1):61-73. PubMed ID: 37962045
[TBL] [Abstract][Full Text] [Related]
2. Tumor-derived exosomal circRNA_102481 contributes to EGFR-TKIs resistance via the miR-30a-5p/ROR1 axis in non-small cell lung cancer.
Yang B; Teng F; Chang L; Wang J; Liu DL; Cui YS; Li GH
Aging (Albany NY); 2021 May; 13(9):13264-13286. PubMed ID: 33952725
[TBL] [Abstract][Full Text] [Related]
3. Emerging roles of circUBAP2 targeting miR-370-3p in proliferation, apoptosis, and invasion of papillary thyroid cancer cells.
Xiong H; Yu J; Jia G; Su Y; Zhang J; Xu Q; Sun X
Hum Cell; 2021 Nov; 34(6):1866-1877. PubMed ID: 34346032
[TBL] [Abstract][Full Text] [Related]
4. Circ_0003945: an emerging biomarker and therapeutic target for human diseases.
Zhang X; Ma L; Wan L; Wang H; Wang Z
Front Oncol; 2024; 14():1275009. PubMed ID: 38711855
[TBL] [Abstract][Full Text] [Related]
5. Advanced approaches of the use of circRNAs as a replacement for cancer therapy.
Hama Faraj GS; Hussen BM; Abdullah SR; Fatih Rasul M; Hajiesmaeili Y; Baniahmad A; Taheri M
Noncoding RNA Res; 2024 Sep; 9(3):811-830. PubMed ID: 38590433
[TBL] [Abstract][Full Text] [Related]
6. CircDENND2D Inhibits PD-L1-Mediated Non-Small Cell Lung Cancer Metastasis and Immune Escape by Regulating miR-130b-3p/STK11 Axis.
Chen Y; Chen X; Li Z; Zhu Y; Liu F; Cai J
Biochem Genet; 2023 Dec; 61(6):2691-2709. PubMed ID: 37222962
[TBL] [Abstract][Full Text] [Related]
7. Blood-Derived Extracellular Vesicle-Associated miR-3182 Detects Non-Small Cell Lung Cancer Patients.
Visan KS; Lobb RJ; Wen SW; Bedo J; Lima LG; Krumeich S; Palma C; Ferguson K; Green B; Niland C; Cloonan N; Simpson PT; McCart Reed AE; Everitt SJ; MacManus MP; Hartel G; Salomon C; Lakhani SR; Fielding D; Möller A
Cancers (Basel); 2022 Jan; 14(1):. PubMed ID: 35008424
[TBL] [Abstract][Full Text] [Related]
8. Biogenesis, Functions, and Role of CircRNAs in Lung Cancer.
Dong H; Zhou J; Cheng Y; Wang M; Wang S; Xu H
Cancer Manag Res; 2021; 13():6651-6671. PubMed ID: 34466035
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic value of microRNA-2355-3p and contribution to the progression in lung adenocarcinoma.
Zhao Y; Zhang W; Yang Y; Dai E; Bai Y
Bioengineered; 2021 Dec; 12(1):4747-4756. PubMed ID: 34334103
[TBL] [Abstract][Full Text] [Related]
10. Circ_0067934 promotes non-small cell lung cancer development by regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway.
Zhao M; Ma W; Ma C
Biomed Pharmacother; 2020 Sep; 129():110461. PubMed ID: 32768951
[TBL] [Abstract][Full Text] [Related]
11. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
[TBL] [Abstract][Full Text] [Related]
12. Pericytes in the Premetastatic Niche.
Paiva AE; Lousado L; Guerra DAP; Azevedo PO; Sena IFG; Andreotti JP; Santos GSP; Gonçalves R; Mintz A; Birbrair A
Cancer Res; 2018 Jun; 78(11):2779-2786. PubMed ID: 29789421
[TBL] [Abstract][Full Text] [Related]
13. circUBAP2 exacerbates malignant capabilities of NSCLC by targeting KLF4 through miR-3182 modulation.
Zheng G; Huang J; Chen W; You P; Ding Y; Tu P
Aging (Albany NY); 2021 Mar; 13(8):11083-11095. PubMed ID: 33882454
[TBL] [Abstract][Full Text] [Related]
14. Hsa_circ_0016760 exacerbates the malignant development of non‑small cell lung cancer by sponging miR‑145‑5p/FGF5.
Zhu Z; Wu Q; Zhang M; Tong J; Zhong B; Yuan K
Oncol Rep; 2021 Feb; 45(2):501-512. PubMed ID: 33416186
[TBL] [Abstract][Full Text] [Related]
15. miR-25 enhances cell migration and invasion in non-small-cell lung cancer cells via ERK signaling pathway by inhibiting KLF4.
Ding X; Zhong T; Jiang L; Huang J; Xia Y; Hu R
Mol Med Rep; 2018 May; 17(5):7005-7016. PubMed ID: 29568911
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
